Balance Sheet
Cash Flow Statement
Amortizatization of IntangiblesAmortizatization of IntangiblesCash from Financing ActivitiesCash from Financing ActivitiesCash from Investing ActivitiesCash from Investing ActivitiesCash from OperationsCash from OperationsChange in Account PayablesChange in Account PayablesChange in Accured ExpensesChange in Accured ExpensesChange in Acquisitions & DivestmentsChange in Acquisitions & DivestmentsChange in CashExchange Rate EffectExchange Rate EffectFree Cash FlowFree Cash FlowGains from Investment SecuritiesGains from Investment SecuritiesGains from Sales and DivestituresGains from Sales and DivestituresNet Cash FlowNet Cash FlowNet IncomeNon-cash ItemsNon-cash ItemsShare-based CompensationShare-based CompensationShares Issued
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Viking Therapeutics (VKTX) Change in Account Payables (2016 - 2026)

Viking Therapeutics (VKTX) has disclosed Change in Account Payables for 13 consecutive years, with $13.9 million as the latest value for Q1 2026.

  • For Q1 2026, Change in Account Payables rose 760.24% year-over-year to $13.9 million; the TTM value through Mar 2026 reached $59.5 million, up 2298.35%, while the annual FY2025 figure was $43.4 million, 1786.15% up from the prior year.
  • Change in Account Payables hit $13.9 million in Q1 2026 for Viking Therapeutics, down from $48.8 million in the prior quarter.
  • Across five years, Change in Account Payables topped out at $48.8 million in Q4 2025 and bottomed at -$10.8 million in Q3 2024.
  • Average Change in Account Payables over 5 years is $3.9 million, with a median of $1.7 million recorded in 2022.
  • Year-over-year, Change in Account Payables plummeted 10935.0% in 2024 and then skyrocketed 760.24% in 2026.
  • Viking Therapeutics' Change in Account Payables stood at $5.4 million in 2022, then crashed by 66.57% to $1.8 million in 2023, then soared by 430.87% to $9.6 million in 2024, then skyrocketed by 410.8% to $48.8 million in 2025, then tumbled by 71.48% to $13.9 million in 2026.
  • According to Business Quant data, Change in Account Payables over the past three periods came in at $13.9 million, $48.8 million, and -$1.1 million for Q1 2026, Q4 2025, and Q3 2025 respectively.